CN104130984A - Aflatoxin oxidase acting on versicolorin A - Google Patents

Aflatoxin oxidase acting on versicolorin A Download PDF

Info

Publication number
CN104130984A
CN104130984A CN201410370164.3A CN201410370164A CN104130984A CN 104130984 A CN104130984 A CN 104130984A CN 201410370164 A CN201410370164 A CN 201410370164A CN 104130984 A CN104130984 A CN 104130984A
Authority
CN
China
Prior art keywords
aflatoxin
versicolorin
oxydase
afo
acts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410370164.3A
Other languages
Chinese (zh)
Other versions
CN104130984B (en
Inventor
刘大岭
蒋海兰
姚冬生
谢春芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Fang can animal health care Co.,Ltd.
Original Assignee
Jinan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan University filed Critical Jinan University
Priority to CN201410370164.3A priority Critical patent/CN104130984B/en
Publication of CN104130984A publication Critical patent/CN104130984A/en
Application granted granted Critical
Publication of CN104130984B publication Critical patent/CN104130984B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses aflatoxin oxidase acting on versicolorin A. a key amino acid residue at a substrate binding site of wild aflatoxin oxidase (AFO) is modified through a genetic engineering technology, and an AFO mutant with improved selectivity and compatibility on versicolorin A (Ver A). The mutant aflatoxin oxidase (Mafo555) acting on versicolorin A has the substrate Ver A selectivity improved by 18 times than that of wild AFO, has the substrate Ver A compatibility improved by 6 times than that of wild AFO, and has the Ver A specific enzyme activity improved by 4 times than that of wild AFO.

Description

Act on the aflatoxin oxydase of versicolorin
Technical field
The present invention relates to aflatoxin oxydase, specially refer to the aflatoxin oxydase that acts on versicolorin.
Background technology
Aflatoxin oxydase (Aflatoxin oxidase, AFO) be a kind of intracellular enzyme that derives from Armillariella tabescens (Armillariella tabescens), have the advantages that directly to transform in vitro gang's aflatoxin, research shows: the process that AFO transforms aflatoxin B1 (AFB1) is a redox reaction, is attended by H 2o 2generation, it acts on toxophore-bifuran of AFB1, causes the two bond ruptures of furans in bifuran, thereby changes into non-toxic products.
Versicolorin (Ver A) is the front extract in AFB1 biosynthetic process, in its molecular structure, also there is the bifuran identical with AFB1, utilize the research that enzyme electrodes that AFO (wild-type) makes carries out electrochemical Characterization to Ver A to find that wild-type enzyme electrode pair Ver A has response signal, but sensitivity is low, signal is not obvious.This explanation: although wild-type aflatoxin oxydase also exists transformation to VerA, act on insensitive.
Versicolorin (VerA, versicolorin A) 1,6,8-trihydroxy--2-methylol anthraquinone, aflatoxin B1 and sterigmatocystin (sterigmytocystin, ST) the important as precursors thing in anabolic process, its structure contains the toxophore-bifuran identical with AFB1 and ST.Research shows that to grain the VerA in storage monitors, can be to the forewarning function not yet detecting or only the agricultural-food such as the low-level grain that detects aflatoxin, feed play pollution.Be under original state, the positive of the VerA of certain level detects (even if AFB1 not yet detects or only low-level detecting), can point out pollution level and the Pollution risk of depositing the aflatoxin of these agricultural-food after certain hour under certain condition.Described mutant enzyme of the present invention can sensitively produce oxidizing reaction to VerA rapidly, is assembled on electrode, can access VerA is responded to sensitive biological sensor electrode.In addition, the eighties in 20th century, the preliminary study such as Wong acute toxicity and the teratogenesis sex change of VerA, its LD50 (mouse mainline) is 20mg/kg, mutagenesis dosage (Ames test) is 800ng/ ware, thereby the toxicity of versicolorin itself can not be ignored.
Owing to producing malicious mould, before producing aflatoxin B1, there will be the cumulative process of a Ver A, although wild-type AFO to Ver A is had to a certain degree Decomposition, but the AFO mutant in the present invention is sensitiveer higher with transformation efficiency to the effect of VerA, can stop and disturb in theory and produce the synthetic aflatoxin B1 of malicious mould, thereby reach the object of blocking-up or the formation of retardation aflatoxin B1.
Summary of the invention
Primary and foremost purpose of the present invention is to provide a kind of aflatoxin oxydase that acts on versicolorin.
The present invention carries out rite-directed mutagenesis to the oxidasic gene of the aflatoxin of Armillariella tabescens (being called AFO gene).The aflatoxin oxydase obtaining in Armillariella tabescens (Armillariella tabescens) AS165, be sequenced (A fungal enzyme with the ability of aflatoxin B1conversion:Purification and ESI-MS/MS identification, Microbiological Research 166 (2011) 475-483), GENBANK accession number is AY941095.The aminoacid sequence of this oxidasic maturation protein is SEQ ID NO.1.
According to a kind of Fixedpoint mutation modified aflatoxin oxydase of the present invention, in the aflatoxin oxydase that derives from Armillariella tabescens (Armillariella tabescens) that is SEQ ID NO.1 by aminoacid sequence, manufacturing a plurality of aminoacid replacement produces, the oxydase stronger to versicolorin specificity, described aminoacid replacement is the replacement of the 404th, 410,493,497 and 501.
According to the oxidasic further feature of Fixedpoint mutation modified aflatoxin of the present invention, the described aminoacid replacement at the 404th is to replace α-amino-isovaleric acid with Methionin; At the aminoacid replacement of 410, be to use halfcystine substituted lactamine; Aminoacid replacement at the 493rd is to replace L-glutamic acid with tryptophane; Aminoacid replacement at the 497th is to replace L-glutamic acid with tyrosine; Aminoacid replacement at the 501st is to replace L-glutamic acid with methionine(Met); The described oxidasic aminoacid sequence of Fixedpoint mutation modified aflatoxin is SEQ ID NO.2.
The mutant aflatoxin oxydase (mAFO) that acts on versicolorin of the present invention, its selectivity ratios wild-type AFO to substrate Ver A improves 18 times, and the affinity of substrate Ver A is improved to 6 times than wild-type AFO.To the ratio enzyme activity of Ver A than 4 times of the raisings of wild-type AFO.
Further, the invention provides a kind of DNA molecular, its aflatoxin oxydase that acts on versicolorin of the present invention of encoding.
Preferably, the nucleotides sequence of DNA molecular of the present invention is classified SEQ ID NO.3 as.
Another object of the present invention is to provide a kind of carrier, and it contains DNA molecular of the present invention.
Another object of the present invention is to provide a kind of host cell, and it contains DNA molecular of the present invention, or contains carrier of the present invention.
Above-mentioned carrier and host cell can be prepared by technique means well known in the art.
The present invention also provides the oxidasic production method of aflatoxin that acts on versicolorin of the present invention, comprise: under the condition that is suitable for aflatoxin Oxidase Expression, cultivate host cell of the present invention, and the aflatoxin oxydase described in separated from substratum.
When DNA molecular of the present invention is inserted into described carrier with suitable orientation and correct reading frame, or proceed in described host cell, described DNA molecular can be expressed in any eucaryon or prokaryotic expression system.Many host-vector systems can be used for marking protein encoding sequence.Host-vector system includes but not limited to: the bacterium transforming with phage, plasmid or clay; The microorganism that contains yeast vector, as yeast; Mammalian cell system with virus infection; Insect cell system with virus infection; The vegetable cell system infecting with bacterium.The preferred carrier of the present invention comprises virus vector, plasmid, clay or oligonucleotide.
The preferred host of the present invention be prokaryotic system as subtilis, also can with eukaryotic expression system as pichia spp; Preferred expression method is intestinal bacteria, for example Rosetta (DE3); Purification tag MBP also can select other purification tag, as 6 Histidines.
The preferred protein expression method of the present invention is lactose-induced expression; The solubility expression that more preferably IPTG induces.
The preferred method of purifying protein of the present invention is can for example, with conventional protein chromatography technology, ion exchange chromatography and hydrophobic chromatography coupling; Preferred purification process is affinity chromatography, for example Amylose affinity chromatography.
Further, the present invention also provides a kind of biosensor, and it contains the aflatoxin oxydase that acts on versicolorin of the present invention.
The present invention further provides the purposes of described biosensor, for detection of the purposes of the content of versicolorin in grain, food and raw material thereof, feed.
Accompanying drawing explanation
Fig. 1 shows mAFO 555selectivity (K to Ver A aFB1m/K verAm value).
Embodiment
The term that adopted herein, except as otherwise noted, is the implication that those skilled in the art understand conventionally.The definition of some specific terms that use in the present invention is below provided.
" AFO " represents wild-type Aflatoxin-detofizyme, and its gene represents with italic AFO.
" mAFO " represents mutant Aflatoxin-detofizyme, and its gene represents with mAFO.
" mAFO 555" representing No. 555 mutant Aflatoxin-detofizymes, its gene is with mAFO 555represent.
Embodiment 1: the pcr amplification of Aflatoxin-detofizyme gene and order-checking
1, the present invention with armillariella tabescens source Aflatoxin-detofizyme gene (AY941095.1) sequence as a reference, adopt software Primer 5 to design and synthesize two Oligonucleolide primers, PBA plasmid in alkaline lysis method of extracting DH-5a, by PCR method amplifying target genes AFO.
Article two, PCR primer is as follows:
Forward primer: 5 ' ATGGCCACCACAACTGTCCACCGG 3 '
Reverse primer: 5 ' CGC gGATCCtCACAATCGTCTCTCAATGAAAC 3 '
Line part is BamH I restriction enzyme site.
PCR reaction system is as follows:
PBA (template) 1.6ul
Forward primer 1.2ul
Reverse primer 1.2ul
10xKOD damping fluid 4ul
KOD-Plus-NEO 0.8ul
DNTP 4ul
ddH 2O 24.8ul
PCR program setting:
94 ℃ of denaturation 5min;
94 ℃, 40s; 55 ℃, 40s; 68 ℃, 5 circulations of 65S;
94 ℃, 40s; 62 ℃, 40s; 68 ℃, 25 circulations of 65S;
68℃,5min。
Pcr amplification product, after 1% agarose gel electrophoresis, reclaims test kit with DNA and carries out glue recovery, obtains the fragment of about 2.1kb.
Embodiment 2: Aflatoxin-detofizyme gene (AFO) is connected with expression vector pMAL-C2X's
1. expression vector pMAL-C2X is carried out to restriction enzyme BamH I, PdmI double digestion, mAFO goal gene carries out restriction enzyme BamH I single endonuclease digestion, in 37 ℃ of enzymes, cuts 10min, and enzyme tangent condition is as follows:
2. enzyme is cut product and after 1% agarose gel electrophoresis, is reclaimed respectively two object fragments, with T4DNA ligase enzyme, connects, and linked system is as follows:
AFO enzyme is cut product 13ul
PMAL-C2X enzyme is cut product 4ul
T4DNA enzyme 0.2ul
10 * damping fluid 2ul
ddH 2O 0.8ul
Total amount 20ul
With 22 ℃ of ligase enzymes, connect 3h, connect after product transforms the amplification of Rosetta (DE3) competent cell and use plasmid extraction test kit extracting plasmid, with running electrophoresis result after SacI/BamHII double digestion, show 6.6kb and 2.1kb two bands, show successful connection, by DNA sequencing, be defined as Aflatoxin-detofizyme gene.
Embodiment 3: rite-directed mutagenesis
1,, through utilizing DS3.0 software platform to carry out bioinformatic analysis to the simulation three-dimensional structure of aflatoxin toxin detoxication enzyme, we are definite carries out Fixedpoint mutation modified to the amino acid in following site:
(1) for the amino acid mutation of the 404th amino acids, design primer is as follows:
mAFO V404K
Forward mutation primer:
5’ATTTTGGCGGCCAAGAAGCCAAACGAGGAGTTAAC?3’SEQ?ID?NO.6
Inverse transition primer:
5’GTTAACTCCTCGTTTGGCTTCTTGGCCGCCAAAAT?3’SEQ?ID?NO.7
(2) for the 410th amino acids sudden change, design primer is as follows:
mAFO V404K/T410C
Forward mutation primer:
5’CAAACGAGGAGTTATGCTTCATCCATCCTGATG?3’SEQ?ID?NO.8
Inverse transition primer:
5’CATCAGGATGGATGAAGCATAACTCCTCGTTTG?3’SEQ?ID?NO.9
(3) for the 497th and the sudden change of 501 amino acids, design primer is as follows:
mAFO V404K/T410C/E497Y/L501M
Forward mutation primer:
5’GAATGCTGGGCGTACACCGTAGCGATGTACTTGGTTAGC?3’SEQ?ID?NO.10
Inverse transition primer:
5’GCTAACCAAGTACATCGCTACGGTGTACGCCCAGCATTC?3’SEQ?ID?NO.11
(4) for 493 amino acids sudden changes, design primer is as follows:
mAFO V404K/T410C/E493W/E497Y/L501M
Forward mutation primer: 5 ' GTCGTCAATGGAATGGTGTCGGGCGTAC 3 ' SEQ ID NO.12
Inverse transition primer: 3 ' GTACGCCCGACACCATTCCATTGACGAC 3 ' SEQ ID NO.13
PCR program setting:
94 ℃ of denaturation 2min;
94 ℃, 30s; 63 ℃, 30s; 68 ℃, 5 circulations of 65S;
94 ℃, 30s; 59 ℃, 30s; 68 ℃, 25 circulations of 65S;
68℃,5min。
After PCR reaction, connect order-checking.Site-directed point mutation is the method that adopts overlapping extension PCR, successively five sites is suddenlyd change, and the DNA sequence dna finally obtaining can be expressed as the aflatoxin oxydase that the present invention acts on versicolorin, and this enzyme is called " mAFO 555".
Embodiment 4:Rosetta (DE3)-pMAL-C2X-mAFO 555solubility induction and MBP-mAFO 555the expression of fusion rotein
By Rosetta (DE3)-pMAL-C2X-mAFO solubility abduction delivering condition is come fusion rotein MBP-mAFO 555carry out abduction delivering.Purification tag MBP is maltose binding protein (Maltose-binding protein).With lactose operon, as promotor, carry out protein table, and more excellent with isopropylthio β-D-galactoside (Isopropylthio-β-D-galactoside, IPTG), the latter can be added on and in substratum, carry out successive induction expression.
(1) draw 10 μ LRosetta (DE3)-pMAL-C2X-mAFO 555glycerine is preserved bacterium liquid in 990 μ L LB liquid nutrient mediums, and hand mixing, is then diluted to 10 with LB liquid nutrient medium gently 4, 10 5, 10 6, 10 7, 10 8six concentration gradients;
(2) draw 100 μ L/ plates 10 5, 10 6, 10 7, 10 8the bacterium liquid of five concentration is coated in the LB solid medium that contains penbritin (100 μ g/mL), after drying at room temperature, in 37 ℃, is inverted overnight incubation;
(3) the good single bacterium colony of growing way on toothpick picking flat board, is placed in the LB liquid nutrient medium that contains penbritin (100 μ g/mL), and 37 ℃ of 150rpm/min overnight shakings are cultivated;
(4) overnight culture is seeded to the rich medium that contains penbritin (100 μ g/mL) and glucose (0.2%) by 1:100, and it is 0.4~0.8 that 37 ℃ of 150rpm/min are cultured to OD600;
(5) adding IPTG is 0.24mM to final concentration, and 20 ℃ of 150rpm/min carry out abduction delivering 60 hours.
(6) 2000~1000g, 4 ℃ centrifugal, results thalline, and freezing preservation.
Embodiment 5: fusion rotein MBP-mAFO 555" isolation and purification
(1) under fermenting culture room temperature, thaw, add 25mL Column buffer to mix, the resuspended liquid of the thalline after thawing is taken out to 25mL and be placed in ice-water bath;
(2) ultrasonication parameter being set is: intermittently 10 seconds, and ultrasonic 5 seconds, power 800W.Ice-bath ultrasonic fragmentation is until bacteria suspension becomes clear;
At (3) 4 ℃ 9, centrifugal 20 minutes of 000g, get supernatant be stored in 4 ℃ standby;
(4) in the pillar that is 1.0 * 20cm by 15mL Amylose Filled Dielectrics in specification.Ultrapure water Peak Flow Rate compression leg 2h.Connect nucleic acid-protein detector, use Column buffer balance pillar to baseline stability.
(5) loading volume: every mL column volume can be in conjunction with 3mg fused protein.
(6) use peristaltic pump with the flow velocity loading of 0.2mL/min broken wall supernatant, after end of the sample, use Column Buffer with same uniform flow wash-out;
(7) when loading starts, observe the ultraviolet absorption value of nucleic acid-protein detector 280nm, collect elutriant when absorption value starts to raise, stop receiving while being eluted to baseline, the solution of herein collecting is the drip washing peak of affinity chromatography;
(8) with Column Buffer+10mM maltose wash-out fused protein.When nucleic acid-protein detector 280nm place absorption value starts to raise, collect elutriant, stop receiving while being eluted to baseline, the solution of herein collecting is MBP-mAFO 555.
(9) with reference to pMAL system specification (reagent handbook), 4 ℃, the MBP-mAFO that affinity chromatography obtains 555fusion rotein is cut 36 hours with Factor Xa enzyme.
The removal of embodiment 6:MBP label and target protein mAFO 555acquisition
Protein product is carried out after corresponding affinity chromatography and enzyme cut, again carrying out affinity chromatography and just can obtaining the target protein of purifying.
(1) in the pillar that is 1.0 * 20cm by 15mL Amylose Filled Dielectrics in specification.Ultrapure water Peak Flow Rate compression leg 2h.Connect nucleic acid-protein detector, use Column buffer balance pillar to baseline stability.
(2) loading volume: every mL column volume can be in conjunction with 3mg fused protein.
(3) will contain MBP label and mAFO 555mixing solutions and column-loading buffer Column Buffer in the ratio of 1:5, mix, with peristaltic pump with the flow velocity loading of 0.2mL/min;
(4) after end of the sample, use Column Buffer with same uniform flow wash-out, when starting, loading observes the ultraviolet absorption value of nucleic acid-protein detector 280nm, when absorption value starts to raise, collect elutriant, stop receiving while being eluted to baseline, the solution of herein collecting is and contains mAFO 555component.
Embodiment 7: object mAFO 555character measure
1, act on the oxidasic property testing of aflatoxin of versicolorin:
1. by the micro-calorimeter of Auto-iTC200 type isothermal titration, measure mAFO 555the affinity of/wtAFO to AFB1/Ver A.Method is as follows:
Adopt single titration method, using Ver A/AFB1 solution as titrating solution, mAFO 555/ wtAFO solution is as titrate, and single titration volume is 25uL, and the time length is 50s, and be 2000s interval time, and feedback model is High, and temperature is 30 ℃, and stirring velocity is 700r/min.The deionized water of usining in reference cell is as the thermally equilibrated reference of sample pool.Separately do a blank assay to eliminate the impact of the heat of dilution between solution, with damping fluid, replace sample, with the titration of Ver A/AFB1 solution simultaneously.During each sample titration, the sample preparation of experimental group is as shown in table 1, only uses damping fluid (pH7.4,20mM Tris-HCl) to substitute sample liquid in control group.
Table 1: sample treatment, unit (ul)
(m) AFO drawing from measuring result is respectively with Ver A and AFB 1kinetic constant during as catalytic substrate, in Table 2.The affinity that represents enzyme with 1/Km.
As shown in table 2, AFO compares with wild-type, mAFO 555the affinity of substrate Ver A (1/Km) has been improved to 7.53 times, and the affinity of substrate A FB1 has been reduced to 0.56 times.
Table 2:mAFO 555kinetic constant
MAFO is to Ver A and AFB 1selectivity as shown in Figure 1.By (1/Km verA)/(1/Km aFB1) (be Km aFB1/ Km verA) can evaluate mAFO 555selectivity between substrate Ver A and AFB1.This value shows more greatly mAFO 555selectivity to Ver A is higher, the less mAFO that shows of this value 555to AFB 1selectivity higher.Result shows: mAFO 555to the selectivity of substrate Ver A, be 19.4 times of wild-type AFO.
2, enzyme activity determination:
Take VerA as substrate, measure the amount (as shown in Equation 1) of the hydrogen peroxide of this substrate generation of enzyme catalysis.HRP in formula: horseradish peroxidase; RBG: negative BG; BG: BG.Under the condition existing at HRP, the hydrogen peroxide (H producing in reaction process 2o 2) more, the amount that RBG changes into BG is more.In 630nm place, measure.
The definition of enzyme activity unit: Yi Ge unit (U) is defined as at 30 ℃, under the condition that pH is 5.8, per minute transforms by Ver A the needed enzyme amount of 1pmol H2O2 that discharges.(m) AFO enzyme activity calculates by following formula 2:
In formula 2:
X d---the AFO enzyme activity of sample diluent, unit: U/ml;
The slope of a---typical curve;
A 0---the absorption value of sample blank group;
A---the absorption value of specimen reaction group;
The intercept of b---typical curve;
2---reaction volume, unit: ml;
10 9---conversion factor, 1mmol=10 9pmol;
1000---conversion factor, 1ml=1000 μ l;
30---the reaction times is 30min;
100---it is 100 μ l that sample diluent adds volume.
Measuring result is as shown in table 3.
The ratio vigor of table 3. enzyme (substrate Ver A)
Enzyme Wild-type AFO (U/mg) mAFO 555(U/mg)
The specific activity of enzyme (2.3±0.3)×10 3 (9.5±0.5)×10 3
2. by the micro-calorimeter of Auto-iTC200 type isothermal titration, measure mAFO 555the selectivity of/wtAFO to AFB1/Ver A.Method is as follows:
Utilize iTC technical measurement mAFO 555km value in the Ver A solution that contains different concns AFB1, titrate mAFO in titration process 555concentration be 10nM, the concentration of titrating solution Ver A is 10 μ M, the concentration of AFB1 is respectively 1/2,1/4,1/5,1/6,1/7,1/8,1/10,1/20,1/40,1/50,1/80,1/100 of Ver A concentration.In titration experiments, adopt single titration method, titration volume is 25uL, and the time length is 50s, and be 2000s interval time, and feedback model is " High ", and temperature is 30 ℃, and stirring velocity is 700r/min.The deionized water of usining in reference cell is as the thermally equilibrated reference of sample pool.

Claims (9)

1. an aflatoxin oxydase that acts on versicolorin, it is characterized in that: in the aflatoxin oxydase that derives from Armillariella tabescens (Armillariella tabescens) that it is SEQ ID NO.1 by aminoacid sequence, manufacture a plurality of aminoacid replacement and produce, the oxydase stronger to versicolorin specificity, described aminoacid replacement is the replacement of the 404th, 410,493,497 and 501.
2. the aflatoxin oxydase that acts on versicolorin according to claim 1, is characterized in that: the described aminoacid replacement at the 404th is to replace α-amino-isovaleric acid with Methionin; At the aminoacid replacement of 410, be to use halfcystine substituted lactamine; Aminoacid replacement at the 493rd is to replace L-glutamic acid with tryptophane; Aminoacid replacement at the 497th is to replace L-glutamic acid with tyrosine; Aminoacid replacement at the 501st is to replace L-glutamic acid with methionine(Met); The described oxidasic aminoacid sequence of Fixedpoint mutation modified aflatoxin is SEQ ID NO.2.
3. a DNA molecular, is characterized in that: its aflatoxin oxydase that acts on versicolorin claimed in claim 2 of encoding.
4. DNA molecular according to claim 3, is characterized in that: its nucleotides sequence is classified SEQ ID NO.3 as.
5. a carrier, is characterized in that: it contains the DNA molecular described in claim 3 or 4.
6. a host cell, is characterized in that: it contains the DNA molecular described in claim 3 or 4, or contains carrier claimed in claim 5.
7. the oxidasic production method of aflatoxin that acts on versicolorin according to claim 1, it is characterized in that, described method comprises: under the condition that is suitable for aflatoxin Oxidase Expression, cultivate host cell claimed in claim 6, and the aflatoxin oxydase described in separated from substratum.
8. a biosensor, is characterized in that: it contains the aflatoxin oxydase that acts on versicolorin claimed in claim 1.
9. biosensor according to claim 8 is for detection of the purposes of the content of the versicolorin in grain, food and raw material thereof, feed.
CN201410370164.3A 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin Active CN104130984B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410370164.3A CN104130984B (en) 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410370164.3A CN104130984B (en) 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin

Publications (2)

Publication Number Publication Date
CN104130984A true CN104130984A (en) 2014-11-05
CN104130984B CN104130984B (en) 2016-09-28

Family

ID=51803838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410370164.3A Active CN104130984B (en) 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin

Country Status (1)

Country Link
CN (1) CN104130984B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016107550A1 (en) * 2014-12-30 2016-07-07 暨南大学 Aflatoxin-detoxifizyme with improved trypsin resistance
CN112760300A (en) * 2021-01-29 2021-05-07 潍坊康地恩生物科技有限公司 Aflatoxin degrading enzyme mutant and production strain thereof
CN117887681A (en) * 2024-03-13 2024-04-16 潍坊新希望六和饲料科技有限公司 Application of horseradish peroxidase in preparation of mildew-removed feed

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1240828A (en) * 1998-06-30 2000-01-12 广东药学院 Process for extracting detoxicating enzyme for aflatoxin B1
CN1712526A (en) * 2004-08-17 2005-12-28 暨南大学 Toxicide enzyme with aflatoxin activity conversion and gene for coding the enzyme

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1240828A (en) * 1998-06-30 2000-01-12 广东药学院 Process for extracting detoxicating enzyme for aflatoxin B1
CN1712526A (en) * 2004-08-17 2005-12-28 暨南大学 Toxicide enzyme with aflatoxin activity conversion and gene for coding the enzyme

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GENBANK: "GenBank:AY941095.1", 《GENBANK》, 18 February 2008 (2008-02-18) *
GENBANK: "GenBank:KF806603.1", 《GENBANK》, 1 February 2014 (2014-02-01) *
GENBANK: "GenBank:Z46234.1", 《GENBANK》, 18 April 2005 (2005-04-18) *
SIXIA WEN ET AL.: "Cloning,expression,purification and characterization of an aflatoxin-converting enzyme from Armillaria tabescens", 《ACTA MICROBIOLOGICA SINICA》, vol. 51, no. 9, 4 September 2011 (2011-09-04) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016107550A1 (en) * 2014-12-30 2016-07-07 暨南大学 Aflatoxin-detoxifizyme with improved trypsin resistance
CN112760300A (en) * 2021-01-29 2021-05-07 潍坊康地恩生物科技有限公司 Aflatoxin degrading enzyme mutant and production strain thereof
CN117887681A (en) * 2024-03-13 2024-04-16 潍坊新希望六和饲料科技有限公司 Application of horseradish peroxidase in preparation of mildew-removed feed
CN117887681B (en) * 2024-03-13 2024-05-24 潍坊新希望六和饲料科技有限公司 Application of horseradish peroxidase in preparation of mildew-removed feed

Also Published As

Publication number Publication date
CN104130984B (en) 2016-09-28

Similar Documents

Publication Publication Date Title
EP3814527B1 (en) Crispr effector system based amplification methods, systems, and diagnostics
Okafor et al. Modern industrial microbiology and biotechnology
McLauchlin The identification of Listeria species
CN106755424A (en) A kind of Escherichia coli ST131 systems bacterial strains detection primer based on CRISPR, kit and detection method
CN103937734B (en) The hyaluronic genetic engineering bacterium of a kind of production and application thereof
Nitta et al. Function of the ςE regulon in dead-cell lysis in stationary-phase Escherichia coli
CN110938579A (en) Recombinant tyrosine ammonia lyase strain, tyrosine ammonia lyase and preparation method and application thereof
Linares et al. Tyramine biosynthesis in Enterococcus durans is transcriptionally regulated by the extracellular pH and tyrosine concentration
CN104130984A (en) Aflatoxin oxidase acting on versicolorin A
CN103834629A (en) Recombinant high-temperature pullulanase and preparation method thereof
CN101880709B (en) Salmonella enteritidis detection reagent kit and method based on loop-mediated isothermal amplification technology
DK157879B (en) CHIMERARY PLASTERING A GENE CODEING A GENER CODE OF A TERMost STORABLE ALFA-AMYLASE, MICRO ORGAN ORGANISMS, MIXTURES, INC.
Hancock et al. Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant
CN107287230A (en) One plasmid vector and its construction method
CN103834745B (en) The quantitative analysis method of milk-acid bacteria and genus bacillus in Daqu microflora
CN105648062A (en) DNA probe, reagent kit and method for detecting deoxyribonuclease
CN101974616A (en) Kit and method for quickly detecting enterotoxin generating escherichia coli
CN103352031B (en) Glycosyltransferase gene and application thereof
CN102443628B (en) Preparation method for nucleic acid quality control by chimeric exogenous independent sequence
CN108359678A (en) A kind of plasmid vector and its construction method of energy high-efficient cloning and temperature-induced expression
CN117210437A (en) Enzyme identification of two gene editing tools and application of enzyme identification in nucleic acid detection
Xu et al. Label free quantitative analysis of Alicyclobacillus acidoterrestris spore germination subjected to low ambient pH
Kamman et al. Optimal conditions for assay of staphylococcal nuclease
CN106086206A (en) Green Wei Si Salmonella loop-mediated isothermal gene amplification fast detecting kit and detection method
CN105734027B (en) A kind of xanthine dehydrogenase and its encoding gene and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210813

Address after: 529339 Building 1, No. 5, Huanxin Road, biaohai Industrial Zone, Shatang Town, Kaiping City, Jiangmen City, Guangdong Province

Patentee after: Guangdong Fang can animal health care Co.,Ltd.

Address before: 510632 No. 601, Whampoa Avenue, Tianhe District, Guangdong, Guangzhou

Patentee before: Jinan University

TR01 Transfer of patent right